Variant report

Variant	esv2422221
Chromosome Location	chr16:59638102-59851643
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr16:59850022-59850206	HepG2	liver:	n/a	chr16:59850074-59850085
2	CEBPB	chr16:59717805-59717880	A549	lung:	n/a	n/a
3	CEBPB	chr16:59640531-59640537	A549	lung:	n/a	n/a
4	CEBPB	chr16:59752932-59753285	A549	lung:	n/a	chr16:59753078-59753089
5	CEBPB	chr16:59667835-59668479	IMR90	lung:	n/a	n/a
6	CEBPB	chr16:59823468-59823509	HepG2	liver:	n/a	chr16:59823484-59823495
7	CEBPB	chr16:59699603-59699905	HepG2	liver:	n/a	chr16:59699727-59699740 chr16:59699728-59699739 chr16:59699729-59699738
8	CEBPB	chr16:59731195-59731541	IMR90	lung:	n/a	n/a
9	CEBPB	chr16:59752998-59753271	K562	blood:	n/a	chr16:59753078-59753089
10	CEBPB	chr16:59639640-59639961	HepG2	liver:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
11	CEBPB	chr16:59639646-59640003	A549	lung:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
12	CEBPB	chr16:59652494-59652790	HepG2	liver:	n/a	chr16:59652665-59652676
13	CEBPB	chr16:59728890-59729203	IMR90	lung:	n/a	chr16:59729056-59729067
14	CEBPB	chr16:59752926-59753295	IMR90	lung:	n/a	chr16:59753078-59753089
15	CEBPB	chr16:59728926-59729209	A549	lung:	n/a	chr16:59729056-59729067
16	CEBPB	chr16:59850016-59850164	H1-hESC	embryonic stem cell:	n/a	chr16:59850074-59850085
17	CEBPB	chr16:59699560-59699871	IMR90	lung:	n/a	chr16:59699727-59699740 chr16:59699728-59699739 chr16:59699729-59699738
18	CEBPB	chr16:59702500-59702739	IMR90	lung:	n/a	chr16:59702597-59702608
19	CEBPB	chr16:59702527-59702671	HepG2	liver:	n/a	chr16:59702597-59702608
20	CEBPB	chr16:59752968-59753260	Hela-S3	cervix:	n/a	chr16:59753078-59753089
21	CEBPB	chr16:59732911-59733165	HepG2	liver:	n/a	n/a
22	CEBPB	chr16:59674551-59674832	HepG2	liver:	n/a	chr16:59674679-59674690 chr16:59674668-59674679
23	CEBPB	chr16:59699676-59699852	A549	lung:	n/a	chr16:59699727-59699740 chr16:59699728-59699739 chr16:59699729-59699738
24	CEBPB	chr16:59728909-59729189	HepG2	liver:	n/a	chr16:59729056-59729067
25	CEBPB	chr16:59799271-59799430	HepG2	liver:	n/a	chr16:59799291-59799302
26	CEBPB	chr16:59775830-59776089	A549	lung:	n/a	chr16:59775920-59775933
27	CEBPB	chr16:59752911-59753298	HepG2	liver:	n/a	chr16:59753078-59753089
28	CEBPB	chr16:59638295-59638509	HepG2	liver:	n/a	chr16:59638376-59638387 chr16:59638376-59638389 chr16:59638376-59638387 chr16:59638377-59638388
29	CEBPB	chr16:59641136-59641336	A549	lung:	n/a	n/a
30	CEBPB	chr16:59639635-59639988	IMR90	lung:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
31	CEBPB	chr16:59638167-59638644	A549	lung:	n/a	chr16:59638376-59638387 chr16:59638376-59638389 chr16:59638185-59638197 chr16:59638376-59638387 chr16:59638377-59638388
32	CEBPB	chr16:59652522-59652789	IMR90	lung:	n/a	chr16:59652665-59652676
33	CEBPB	chr16:59782382-59782691	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPB	chr16:59672961-59673060	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr16:59639781-59639958	K562	blood:	n/a	chr16:59639806-59639817
36	CEBPB	chr16:59674581-59674822	A549	lung:	n/a	chr16:59674679-59674690 chr16:59674668-59674679
37	CEBPB	chr16:59728966-59729119	K562	blood:	n/a	chr16:59729056-59729067
38	CEBPB	chr16:59831123-59831300	HepG2	liver:	n/a	n/a
39	CTCF	chr16:59683088-59683126	GM10248	blood:	n/a	n/a
40	CTCF	chr16:59640000-59640150	AG10803	skin:	n/a	n/a
41	CTCF	chr16:59699980-59700130	WERI-Rb-1	eye:	n/a	n/a
42	CTCF	chr16:59641611-59641652	Spleen_OC	spleen:	n/a	n/a
43	CTCF	chr16:59784691-59784732	Medullo	brain:	n/a	n/a
44	CTCF	chr16:59843733-59843771	GM10248	blood:	n/a	n/a
45	CTCF	chr16:59662481-59662515	GM20000	blood:	n/a	n/a
46	CTCF	chr16:59825900-59826050	HepG2	liver:	n/a	n/a
47	CTCF	chr16:59765560-59765710	HepG2	liver:	n/a	n/a
48	CTCF	chr16:59843400-59843550	GM12878	blood:	n/a	n/a
49	CTCF	chr16:59799520-59799670	GM06990	blood:	n/a	n/a
50	CTCF	chr16:59679660-59679810	HCPEpiC	choroid plexus:	n/a	chr16:59679685-59679701 chr16:59679684-59679702

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:59792836-59792886	HAEpiC	amniotic membrane:	n/a
2	chr16:59789219-59789269	MCF-7	breast:	n/a
3	chr16:59792836-59792886	HAEpiC	amniotic membrane:	n/a
4	chr16:59789219-59789269	MCF-7	breast:	n/a
5	chr16:59789030-59789080	SK-N-SH_RA	brain:	n/a
6	chr16:59788951-59789001	AG09319	gingival:	n/a
7	chr16:59788728-59788778	IMR90	lung:	fetal
8	chr16:59788951-59789001	SAEC	small airway:	n/a
9	chr16:59789071-59789121	NHDF-neo	bronchial:	n/a
10	chr16:59788951-59789001	RPTEC	kidney:	n/a
11	chr16:59656293-59656343	BE2_C	brain:	n/a
12	chr16:59789219-59789269	AG10803	skin:	n/a
13	chr16:59788951-59789001	HRCEpiC	kidney:	n/a
14	chr16:59656293-59656343	HCT-116	colon:	n/a
15	chr16:59790180-59790230	HNPCEpiC	eye:	n/a
16	chr16:59790180-59790230	HAEpiC	amniotic membrane:	n/a
17	chr16:59789030-59789080	PrEC	prostate:	n/a
18	chr16:59789485-59789535	HMEC	breast:	n/a
19	chr16:59789071-59789121	HCF	heart:	n/a
20	chr16:59790180-59790230	PANC-1	pancreas:	n/a
21	chr16:59786279-59786329	AG10803	skin:	n/a
22	chr16:59789030-59789080	K562	blood:	n/a
23	chr16:59789485-59789535	HUVEC	blood vessel:	n/a
24	chr16:59788728-59788778	AG09319	gingival:	n/a
25	chr16:59656293-59656343	NB4	blood:	n/a
26	chr16:59788951-59789001	SKMC	muscle:	n/a
27	chr16:59789071-59789121	HIPEpiC	eye:	n/a
28	chr16:59792836-59792886	K562	blood:	n/a
29	chr16:59790082-59790132	HPAEpiC	pulmonary alveolar:	n/a
30	chr16:59656293-59656343	Hela-S3	cervix:	n/a
31	chr16:59789219-59789269	A549	lung:	n/a
32	chr16:59788951-59789001	ProgFib	skin:	n/a
33	chr16:59792836-59792886	HUVEC	blood vessel:	n/a
34	chr16:59656293-59656343	Jurkat	blood:	n/a
35	chr16:59656293-59656343	GM06990	blood:	n/a
36	chr16:59788728-59788778	SK-N-SH_RA	brain:	n/a
37	chr16:59789071-59789121	AG09319	gingival:	n/a
38	chr16:59790180-59790230	GM12891	blood:	n/a
39	chr16:59786279-59786329	H1-hESC	embryonic stem cell:	embryo
40	chr16:59790180-59790230	SK-N-SH	brain:	n/a
41	chr16:59788951-59789001	IMR90	lung:	fetal
42	chr16:59786279-59786329	PrEC	prostate:	n/a
43	chr16:59786279-59786329	SK-N-SH_RA	brain:	n/a
44	chr16:59788951-59789001	U87	brain:	n/a
45	chr16:59656293-59656343	SAEC	small airway:	n/a
46	chr16:59789030-59789080	ECC-1	luminal epithelium:	n/a
47	chr16:59789030-59789080	HCM	heart:	n/a
48	chr16:59656293-59656343	HEEpiC	esophagus:	n/a
49	chr16:59790180-59790230	NH-A	brain:	n/a
50	chr16:59788728-59788778	GM19239	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr16:59710678..59713121-chr16:59778438..59780009,2	K562	blood:
2	chr16:59802014..59804199-chr16:59814012..59816551,2	K562	blood:
3	chr16:59635524..59637585-chr16:59638803..59640976,2	K562	blood:
4	chr16:59802014..59804199-chr16:59814012..59816551,2	K562	blood:
5	chr16:59730238..59732939-chr3:97563003..97565712,2	MCF-7	breast:
6	chr16:59710678..59713121-chr16:59778438..59780009,2	K562	blood:
7	chr16:59772981..59773721-chrX:108093803..108094584,2	HCT-116	colon:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-105C20.2.1-5	chr16:59743897-59744027	NONHSAT142892
2	lnc-RP11-105C20.2.1-5	chr16:59788045-59789095	NONHSAT142893
3	lnc-RP11-105C20.2.1-5	chr16:59788689-59788752	NONHSAT142892
4	lnc-SETD6-13	chr16:59690034-59690240	NONHSAT142891
5	lnc-SETD6-13	chr16:59689506-59689824	NONHSAT142891
6	lnc-RP11-105C20.2.1-5	chr16:59785865-59785999	NONHSAT142892
7	lnc-RP11-105C20.2.1-5	chr16:59744120-59744199	NONHSAT142892
8	lnc-RP11-105C20.2.1-5	chr16:59788365-59788930	NONHSAT142894

Variant related genes	Relation type
ENSG00000260240	TF binding region
APOOP5	TF binding region
ENSG00000270222	TF binding region
ENSG00000260240	CpG island
APOOP5	CpG island
ENSG00000270222	CpG island

Extended variants
information (count: 5028 )
Associated
traits (count: 75 )

Variant overlapped rSNPs/rCNVs (count:5028 , 50 per page) page: 1 2 3 4 5 6 7 ... 101

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs546797139	chr16:59638166-59638167	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs148494902	chr16:59638173-59638174	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs142499250	chr16:59638185-59638186	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs80015040	chr16:59638204-59638205	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs575130612	chr16:59638254-59638255	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs539059393	chr16:59638260-59638261	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs191454782	chr16:59638269-59638270	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs577104940	chr16:59638340-59638341	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs173759	chr16:59638393-59638394	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs182533026	chr16:59638424-59638425	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs138458511	chr16:59638431-59638432	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs574705257	chr16:59638446-59638447	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs170181	chr16:59638459-59638460	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs150940460	chr16:59638492-59638493	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs531078428	chr16:59638511-59638512	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs554341041	chr16:59638529-59638530	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs552275305	chr16:59638539-59638540	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs373310953	chr16:59638572-59638573	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs77281464	chr16:59638584-59638585	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs140759406	chr16:59638586-59638587	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs531995540	chr16:59638658-59638659	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs17796544	chr16:59638663-59638664	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs454811	chr16:59638668-59638669	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs562241051	chr16:59638672-59638673	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs535294494	chr16:59638692-59638693	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs188052125	chr16:59638703-59638704	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs192406602	chr16:59638727-59638728	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs312135	chr16:59638779-59638780	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs533822688	chr16:59638785-59638786	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs557307822	chr16:59638786-59638787	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs572525431	chr16:59638797-59638798	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs534949670	chr16:59638803-59638804	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs553258164	chr16:59638854-59638855	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs574643754	chr16:59638878-59638879	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs536603083	chr16:59638891-59638892	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs117003714	chr16:59638899-59638900	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs547506087	chr16:59638910-59638911	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs184812994	chr16:59638964-59638965	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs572947534	chr16:59638985-59638986	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs577957958	chr16:59639021-59639022	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs147708631	chr16:59639038-59639039	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs546302120	chr16:59639093-59639094	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs564440724	chr16:59639146-59639147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs187807002	chr16:59639179-59639180	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs545279398	chr16:59639221-59639222	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs76610438	chr16:59639228-59639229	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs191963519	chr16:59639236-59639237	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs146863145	chr16:59639238-59639239	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs185290049	chr16:59639244-59639245	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs543120604	chr16:59639287-59639288	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:75)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21364760	CNVD
Ewing''s sarcoma	17952124	CNVD
Bladder cancer	21909424	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Infertility	21528002	CNVD
Breast cancer	21806811	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Neurodevelopmental disorder	22521361	CNVD
Glioblastoma multiforme	22286061	CNVD
Autism	18414403	CNVD
Breast cancer	20409316	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Ovarian cancer	21720365	CNVD
Leiomyosarcoma	16982739	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	20972252	CNVD
Invasive breast cancer	20972252	CNVD
Breast cancer	17142309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:345 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:59625600-59639400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr16:59631800-59638400	Weak transcription	HSMM	muscle
3	chr16:59635200-59640200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr16:59635600-59638200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr16:59635600-59639800	Weak transcription	NHDF-Ad	bronchial
6	chr16:59637800-59639600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr16:59637800-59645600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr16:59638200-59639000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr16:59638400-59638600	Enhancers	HSMM	muscle
10	chr16:59639000-59639400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr16:59639400-59639800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr16:59639400-59640000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr16:59639600-59640000	Enhancers	Pancreatic Islets	Pancreatic Islet
14	chr16:59639800-59640000	Enhancers	NHDF-Ad	bronchial
15	chr16:59640200-59645000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr16:59643400-59643600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
17	chr16:59644200-59644600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr16:59644600-59650600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr16:59645000-59645200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
20	chr16:59645000-59645600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr16:59645000-59646000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
22	chr16:59645000-59646000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
23	chr16:59645000-59646000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
24	chr16:59645200-59645600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
25	chr16:59645200-59645800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
26	chr16:59645400-59646000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
27	chr16:59645400-59646000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
28	chr16:59645600-59648400	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr16:59645600-59650200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr16:59645800-59647000	Enhancers	iPS-20b Cell Line	embryonic stem cell
31	chr16:59646000-59646400	Enhancers	ES-I3 Cell Line	embryonic stem cell
32	chr16:59646000-59646400	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr16:59646000-59646400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
34	chr16:59646000-59646800	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr16:59646000-59647000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
36	chr16:59646000-59647000	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr16:59646000-59647000	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr16:59646200-59647000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr16:59646400-59646600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
40	chr16:59646400-59647000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
41	chr16:59646400-59647000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
42	chr16:59646600-59647000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
43	chr16:59647000-59648000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
44	chr16:59647000-59648000	Enhancers	H9 Cell Line	embryonic stem cell
45	chr16:59647000-59648200	Weak transcription	HUES6 Cell Line	embryonic stem cell
46	chr16:59647800-59650200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr16:59648000-59648800	Weak transcription	H9 Cell Line	embryonic stem cell
48	chr16:59648200-59648400	Enhancers	ES-I3 Cell Line	embryonic stem cell
49	chr16:59648200-59648400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
50	chr16:59648200-59648600	ZNF genes & repeats	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links